Innoviva (INVA) FCF Payout Ratio Growth (3y) (2017 - 2022)
Innoviva (INVA) FCF Payout Ratio Growth (3y) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 25.39% |
| Jun 30, 2022 | 752.93% |
| Sep 30, 2021 | 74.12% |
| Jun 30, 2021 | 147.90% |
| Mar 31, 2021 | 419.69% |
| Dec 31, 2020 | 118.58% |
| Jun 30, 2020 | 276.71% |
| Mar 31, 2020 | 346.75% |
| Dec 31, 2019 | -275.76% |
| Sep 30, 2019 | 313.00% |
| Jun 30, 2019 | -73.06% |
| Dec 31, 2018 | 22.45% |
| Sep 30, 2018 | -85.55% |
| Jun 30, 2018 | -89.49% |
| Mar 31, 2018 | 25.99% |
| Dec 31, 2017 | -96.07% |
| Sep 30, 2017 | 26.00% |